MedPath

Metabolic and Inflammatory Responses to Hemodialysis and the Effect of a Meal

Not Applicable
Completed
Conditions
Kidney Failure, Chronic
Interventions
Dietary Supplement: Double meal
Registration Number
NCT01446302
Lead Sponsor
University of Aarhus
Brief Summary

The objective of this study is to characterize the hormonal and inflammatory responses to hemodialysis, and to determine the effect of a meal versus fast on the metabolic changes in the post-dialytic phase.

Detailed Description

Studies show that hemodialysis (HD) is a protein catabolic event per se and probably contributes to the high prevalence of protein-energy wasting among HD patients. The muscle catabolic effect of HD is probably caused by loss of amino acids (10-12 grams per dialysis session) and by exacerbation of the inflammatory and hormonal disorders already present. Activation of the immune system during HD has been linked to the contact of blood cells with the dialyzer membrane and to bacterial-derived DNA fragments in the dialysis fluid. An intradialytic increase in interleukin-6 (IL-6) has been shown to correlate with muscle protein catabolism, and because IL-6 continues to increase for 2 hours after HD has ended, there might be a considerable "carry-over effect" to the post-dialytic period. Moreover, HD induces significant changes in the insulin/insulin-like growth factor I (IGF-I) signaling pathways. Plasma insulin is cleared by HD, and the bioactivity of IGF-I is reduced by 50% during a 4-hr maintenance HD due to an up-regulation of IGF-binding protein 1 (IGFBP-1), the only acutely regulated IGFBP.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
24
Inclusion Criteria

Not provided

Read More
Exclusion Criteria

Not provided

Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Double meal on a HD dayDouble mealA standardized meal is served 1 h after start of HD and 1 h after end of HD
Primary Outcome Measures
NameTimeMethod
Changes in serum Bioactive IGF-I and IGFBP-1 levels during and after hemodialysisAt 1, 2, 3, 5, 6, 7, 9, and 10 hours after start of hemodialysis
Changes in plasma Interleukin-6 and serum hsCRP levels during and after hemodialysisAt 1, 2, 3, 5, 6, 7, 9, and 10 hours after start of hemodialysis
Secondary Outcome Measures
NameTimeMethod
Pulse wave analysis (augmentation index (AIx)) during and after hemodialysisAt 1, 2, 3, ,4, 5, 6, 7, 8, 9, and 10 hours after start of hemodialysis
Mineral metabolism (including calcium, phosphate, PTH, and FGF-23 levels) during and after hemodialysisAt 1, 2, 3, 5, 6, 7, 9, and 10 hours after start of hemodialysis

Trial Locations

Locations (2)

Department of Nephrology, Aarhus University Hospital, Skejby

🇩🇰

Aarhus N, Denmark

Department of Nephrology, Viborg Regional Hospital

🇩🇰

Viborg, Denmark

© Copyright 2025. All Rights Reserved by MedPath